Lilly Defeats Cymbalta Label Suit As Possible MDL Looms
A New York federal judge on Friday ruled Eli Lilly & Co.'s label for antidepressant drug Cymbalta adequately warned doctors about possible withdrawal symptoms and tossed a suit claiming the label...To view the full article, register now.
Already a subscriber? Click here to view full article